Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zenwise is a leading consumer health and nutraceutical company that specializes in high-quality dietary supplements for digestive, joint, and cognitive health. The company is widely recognized for its Digestive Enzymes line, which combines multi-enzyme blends with prebiotics and probiotics to support gut health and nutrient absorption. Zenwise utilizes clinically validated ingredients, such as the DE111 probiotic strain, to provide science-backed wellness solutions to consumers. Headquartered in Orlando, Florida, the company maintains a strong presence in both e-commerce and traditional retail channels. In 2021, Zenwise was acquired by The Emerson Group, a consumer products brand management firm, to further scale its market reach. The brand focuses on non-GMO, allergen-conscious formulations designed for modern lifestyle needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zenwise.